StockWatch
·

SELLAS Life Sciences Group, Inc.

Ticker: 1390478

values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-21.91-6.977.9722.91Q1 FY21Q2 FY21Q2 FY21Q1 FY22Q1 FY22

Margin Trend

percentage
OPM %NPM %
-109.09-82.83-56.56-30.29Q1 FY21Q2 FY21Q2 FY21Q1 FY22Q1 FY22
PeriodQ1 FY22Q1 FY22Q2 FY21Q2 FY21Q1 FY21
INCOME
Revenue1.00+0.0%1.00-47.4%1.90+0.0%1.90-66.7%5.70
Total Income1.00+0.0%1.00-47.4%1.90+0.0%1.90-66.7%5.70
EXPENSES
Expenditure17.74+0.0%17.74+179.4%6.35+0.0%6.35-20.1%7.95
PROFIT
Net Profit-16.74+0.0%-16.74-263.1%-4.61+0.0%-4.61-92.1%-2.40
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-60.61pp-39.39%
NPM %-100.00%-100.00%-100.00%-100.00%-57.84pp-42.16%
EPS-1.05+0.0%-1.05-250.0%-0.30+0.0%-0.30—

Corporate Events

Board MeetingSLS
2026
24Jun

Board Meeting

Amendments to compensatory arrangements for Dr. Angelos Ster…

SEC Filing ↗
Board MeetingSLS
2026
16Jun

Board Meeting

Results of the Annual Meeting of Stockholders, including the…

SEC Filing ↗